Since hyperglycemia and dyslipidemia are the two primary metabolic challenges in T2D management [23], routinely monitored through biomarkers such as HbA1c, FBG, insulin, TGs, TC, and LDL-C, there is high importance in investigating herbal products as adjunctive therapies alongside conventional treatment. The gene discussed is INS; the disease is metabolic syndrome.